GYNECOLOGIC COMMITTEE - SWOG
GYNECOLOGIC COMMITTEE - SWOG
GYNECOLOGIC COMMITTEE - SWOG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Program Director/Principal Investigator (Last, First, Middle):<br />
Baker, Laurence H., D.O.<br />
disease after primary surgery and chemotherapy: an intergroup<br />
study. DS Alberts, EV Hannigan, PY Liu, C Jiang, S Wilczynski,<br />
L Copeland, M Markman. Gynecologic Oncology 100:133-138, 2006.<br />
PMID: 16153694<br />
S9701/9326 Pretreatment CA-125 and risk of relapse in advanced 11/15/97 12/01/01<br />
ovarian cancer. M Markman, PY Liu, M Rothenberg, 9/1/93 7/1/97<br />
BJ Monk, M Brady, DS Alberts. Journal of Clinical<br />
Oncology 24(9):1454-1458, 2006. PMID: 16549840<br />
S9717 Tirapazamine plus cisplatin in advanced or recurrent 8/15/98 8/15/00<br />
carcinoma of the uterine cervix: a Southwest Oncology<br />
Group study. HO Smith, CS Jiang, GR Weiss, AV Hallum III,<br />
PY Liu, WR Robinson III, PC Cheng, SA Scudder,<br />
M Markman, DS Alberts. International Journal of<br />
Gynecological Cancer 16:298-305, 2006. PMID:<br />
16445649<br />
G0167 Concurrent endometrial carcinoma in women with a 7/15/01 2/24/03<br />
biopsy diagnosis of atypical endometrial hyperplasia:<br />
A Gynecologic Oncology Group Study. CL Trimble,<br />
J Kauderer, R Zaino, S Silverberg, PC Lim, JJ Burke,<br />
DS Alberts, J Curtin. Cancer 106(4):812-819, 2006.<br />
PMID: 16400639<br />
GYN ABSTRACTS PUBLISHED/PRESENTED (2006)<br />
S9701 A modified CA-125 progression criterion in ovarian cancer 11/15/97 12/01/01<br />
(OC) patients (pts) receiving maintenance treatment following<br />
complete clinical response (cCR) to primary therapy. P Liu,<br />
J Moon, DS Alberts, BJ Monk, M Brady, M Markman.<br />
Proc of the American Society of Clinical Oncology,<br />
Journal of Clinical Oncology 24(18S):#5080, 2006.<br />
http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/5080?maxtoshow<br />
=&HITS=10&hits=10&RESULTFORMAT=&fulltext=liu&searchid=1&FIRSTIND<br />
EX=10&volume=24&issue=18_suppl&resourcetype=HWCIT<br />
S9701 Survival (S) of ovarian cancer (OC) patients (pts) treated 11/15/97 12/01/01<br />
on <strong>SWOG</strong> 9701/GOG178: 12 versus (v) 3 cycles (c) of<br />
monthly single-agent paclitaxel (PAC) following attainment<br />
of a clinically –defined complete response (CR) to platinum<br />
(PLAT)/PAC. M Markman, PY Liu, S Wilczynski, B Monk,<br />
LJ Copeland, D Alberts. Proc of the American Society of<br />
Clinical Oncology, Journal of Clinical Oncology 24(18S):<br />
#5005, 2006.<br />
http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/5005?maxtoshow<br />
=&HITS=10&hits=10&RESULTFORMAT=&fulltext=markman&searchid=1&FIRS<br />
TINDEX=0&volume=24&issue=18_suppl&resourcetype=HWCIT<br />
GYN MANUSCRIPTS PUBLISHED/PRESENTED (2007)<br />
S9701 An early signal of CA-125 progression for ovarian cancer 11/15/97 12/01/01<br />
patients receiving maintenance treatment after complete<br />
clinical response to primary therapy. PY Liu, DS Alberts,<br />
BJ Monk, M Brady, J Moon, M Markman. Journal of Clinical<br />
Oncology 25(24):3615-3620, 2007. PMID: 17704410<br />
S0211 Phase II trial of imatinib mesylate in recurrent, biomarker 4/15/02 01/01/06<br />
positive, ovarian cancer (Southwest Oncology Group<br />
Protocol S0211). DS Alberts, PY Liu, SP Wilczynski, A Jang,<br />
J Moon, JH Ward, JT Beck, M Clouser, M Markman.<br />
International Journal of Gynecological Cancer 17:784-788,<br />
2007. PMID: 17343607<br />
<strong>GYNECOLOGIC</strong> <strong>COMMITTEE</strong> GYN- 15
Change language